TipRanks
NexPoint Real Estate ate Finance (NREF)
NYSE:NREF
US Market
Want to see NREF full AI Analyst Report?
EarningsQ2 2026 Earnings Report

NexPoint Real Estate ate Finance (NREF) Q2 2026 Earnings Report

222 Followers

NREF Q2 2026 EPS Results

Actual EPS$0.46
Consensus EPS$0.40
Beat/MissBeat by +$0.06
One Year Ago EPS$0.43

NREF Q2 2026 Revenue Results

Actual Revenue$34.32M
Expected Revenue―
Beat/Miss―
YoY Revenue Growth+9.15%

Earnings Announcement Details

QuarterQ2 2026
Date08/06/2026
TimeBefore Open
Conference CallThursday, August 6, 2026
NREF Upcoming Earnings
NexPoint Real Estate ate Finance's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

NREF Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 06, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a predominantly constructive operational and capital‑markets picture: CAD and EAD increased year‑over‑year, the company executed a material refinancing (Mizuho facility + TRS) that reduced near‑term liability risk and cost pressure, and originations and portfolio metrics showed signs of improvement (residential lease trends, Alewife leasing, self‑storage performance). Key challenges include a large YoY drop in GAAP net income, EAD still trailing the declared dividend (though CAD covers it), modest book value decline, sector/geographic concentration (life science and Massachusetts) and relatively short debt maturities that imply refinancing exposure. Overall, positive execution on capital structure and high‑yield deployments outweigh the remaining earnings volatility and concentration/refinancing risks, with management signaling continued pipeline conversion and credit discipline.
Company Guidance
Management guided Q3 EAD of $0.43 per diluted share at the midpoint (range $0.38–$0.48) and CAD of $0.55 per diluted share at the midpoint (range $0.50–$0.60), and the board declared a $0.50 per share Q3 dividend (matching the Q2 regular dividend); for context Q2 reported net income of $0.29 per diluted share, EAD $0.46, CAD $0.58 with CAD coverage of 1.16x, and book value per diluted share was down 1.9% to $18.60.
Strong Cash Available for Distribution (CAD) Growth and Dividend Coverage
CAD was $0.58 per diluted share in Q2 2026 versus $0.46 in Q2 2025, an increase of ~26%. The company paid a regular dividend of $0.50 per share and CAD coverage was 1.16x. The board declared a $0.50 dividend for Q3 2026.
Earnings Available for Distribution (EAD) Improved Year‑Over‑Year
EAD was $0.46 per diluted share in Q2 2026 compared to $0.43 in Q2 2025, an increase of ~7%.
Successful Capital Markets and Liability Management
Closed a $375 million drawable term loan facility with Mizuho, repaid $180 million 5.75% senior unsecured notes, and have $362.2 million outstanding on the facility. Entered a total return swap (TRS) that reduces net interest cost to SOFR +245 bps and provides flexible, asset‑based financing.
Active, High‑Yield New Originations
Funded a $20.2M preferred equity multifamily investment at a 14% coupon, a $42.6M mezzanine loan secured by a life science property at a 14% coupon, and funded an additional $31.9M on existing commitments. Closed in excess of $70M from the April pipeline during the quarter.
Portfolio Size, Diversification and Stabilization Metrics
Portfolio comprises 85 investments with $1.1B outstanding. Collateral is 80.3% stabilized, weighted average LTV 63.4%, and weighted average DSCR 1.39x.
Improving Residential Operating Trends
Blended lease trade‑outs improved sequentially: April -1.7%, May -1.2%, June -0.5% (‑50 bps) and turned positive +30 bps in July — the first positive blended print since early 2025.
Life Science Asset De‑risking (Alewife) and Broader Demand Improvement
Alewife asset tracking to be 85% leased (up from 71%) anchored by a long‑term 245k sq ft lease. Management reports widened demand funnel for life science assets (AI tailwinds) and tour activity up ~30% Q1→Q2 with July tracking ahead.
Self‑Storage Outperformance and Attractive Pipeline Returns
Self‑storage portfolio occupancy in the low 90s with rent growth and NOI materially ahead of sector. Pipeline (~$190M NREF and $225M+ structured credit) blended returns remain well in excess of cost of capital on the TRS facility.
Guidance Stable for Q3 2026
Q3 midpoint guidance: EAD $0.43 per diluted share (range $0.38–$0.48) and CAD $0.55 per diluted share (range $0.50–$0.60).

NREF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 05, 2026
2026 (Q3)
0.40 / -
0.51―
2026 (Q2)
0.40 / 0.46
0.436.98% (+0.03)
2026 (Q1)
0.37 / 0.42
0.412.20% (<+0.01)
2025 (Q4)
0.49 / 0.48
0.83-42.17% (-0.35)
2025 (Q3)
0.47 / 0.51
0.75-32.00% (-0.24)
2025 (Q2)
0.46 / 0.43
0.68-36.76% (-0.25)
2025 (Q1)
0.49 / 0.41
-0.46189.13% (+0.87)
2024 (Q4)
0.76 / 0.83
0.4488.64% (+0.39)
2024 (Q3)
0.48 / 0.75
0.4374.42% (+0.32)
2024 (Q2)
0.45 / 0.68
0.4647.83% (+0.22)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed